Skip to main content
Veterinary Medicines

Panacur Boli 250 mg Intraruminaal hulpmiddel met continue afgifte

Authorised
  • Fenbendazole

Product identification

Medicine name:
Panacur Boli 250 mg Intraruminaal hulpmiddel met continue afgifte
Panacur Boli 250 mg Dispositif intraruminal à libération continue
Panacur Boli 250 mg Intraruminales System mit kontinuierlicher Freigabe
Active substance:
  • Fenbendazole
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    250.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Continuous-release intraruminal device
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        18
        day
      • Meat and offal
        19
        day
      • Milk
        8
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Panacur Boli 50 Bolus Continuous-release intraruminal device
  • Panacur Boli 20 Bolus Continuous-release intraruminal device

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V116243
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/10/2023
French (PDF)
Published on: 6/10/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 6/10/2023
French (PDF)
Published on: 6/10/2023
German (PDF)
Published on: 6/10/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."